Edgeworth provides expert testimony as well as litigation and business and regulatory consulting to lawyers, companies, and government agencies that are making strategic decisions. Our experts use sophisticated data analysis and sound economic theory to address relevant issues, explaining their work in ways that are easy to understand by non-economists including attorneys, businessmen, judges, and jurors. Explore the cases below to sample our work.
Edgeworth CEO Dr. John Johnson, working with Principal Consultant Dr. David Colino, was retained by AMN Healthcare, a major healthcare staffing company, in an antitrust matter brought by a competitor alleging Section 1 and Section 2 claims.
Edgeworth was retained to respond to the analyses and opinions put forward by Plaintiff’s economic experts. Dr. Colino submitted an expert report in the case analyzing issues relevant to market definition, market power, harm to competition (including pro-competitive benefits of ACT’s alleged conduct), and damages, and was subsequently deposed.
Edgeworth Client Secures Landmark Win in Federal Antitrust Case Alleging Conspiracy to Raise Egg Prices
Edgeworth President Dr. Jesse David testified in federal court in the Eastern District of Pennsylvania, helping secure a landmark win on behalf of Rose Acre Farms.
Edgeworth Economics has consulted on behalf of a wide range of companies, providing ongoing data analysis on the topics of compensation and pay equity.
Dr. Deborah Foster's declaration and supporting exhibits cited and relied upon by California Court of Appeal.
An Edgeworth team analyzed data regarding pregnancy-related leaves of absence and requests for accommodation to address claims against a nationwide retailer.
Managing Principal Sophie Meadows submitted a report and testified in court in a housing dispute in Washington, DC.
Edgeworth Economics was retained by DC Legal Aid to provide economic analyses of allowable rent increases in a landlord-tenant dispute in Washington, DC.
An Edgeworth client obtained a settlement valued at about $60 million, thereby resolving both a patent litigation and an antitrust counter suit.